5021APD811 (ralinepag), a novel non-prostanoid IP receptor agonist, has potent antiproliferative and vasorelaxant properties in human pulmonary artery
Lei Shen(University College London), Lucie H. Clapp(The London College), Xavier Norel(Inserm), Jitesh A. Patel, Dominic P. Behan, John Adams
Cited by 0
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Terlipressin for norepinephrine-resistant septic shock
|The Lancet|2002|259
Vasopressin: Mechanisms of action on the vasculature in health and in septic shock
|Critical Care Medicine|2006|246
Differential Effects of Stable Prostacyclin Analogs on Smooth Muscle Proliferation and Cyclic AMP Generation in Human Pulmonary Artery
|American Journal of Respiratory Cell and Molecular Biology|2002|232